HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Fructose-1-phosphate and fructose-1,6-bisphosphate aldolases in the small intestinal mucosa.

Abstract
Reference values are presented for the activity of fructose-1-phosphate aldolase (F1PA) and fructose-1,6-bisphosphate aldolase (FBPA) in the small intestinal mucosa of 32 nonaffected children, 8 nonaffected adults and 2 children with hereditary fructose intolerance (HFI). The 96% confidence limits for F1PA in children are 1.55 to 43.0 u/g protein, completely distinct from the results of the two affected children (1.3 and less than 0.1 u/g protein). With fructose-1,6-bisphosphate as subtrate, the 96% confidence limits are 10 to 324 u/g protein and the values for the two affected children, 23.7 and 9.3 u/g. Among the nonaffected children two mucosal biopsies with F1PA activities less than 1.55 u/g were found. In one mucosal biopsy among the nonaffected children an FBPA activity less than 10 u/g was recorded. The data are interpreted as indicating that the determination of F1PA activity in intestinal mucosa is a highly sensitive test in detecting individuals with HFI. However, the specifity of the test is not absolute. Diagnosis should be based on both clinical and laboratory considerations. The determination of FBPA activity in the same biopsy specimen does not contribute substantially to the differential diagnosis.
AuthorsZ Lerner, M Cooper, E Granot, E Hegesh
JournalIsrael journal of medical sciences (Isr J Med Sci) Vol. 23 Issue 3 Pg. 185-7 (Mar 1987) ISSN: 0021-2180 [Print] Israel
PMID3583699 (Publication Type: Journal Article)
Chemical References
  • Fructose-Bisphosphate Aldolase
Topics
  • Adult
  • Child
  • Duodenum (enzymology)
  • Fructose Intolerance (diagnosis, enzymology, genetics)
  • Fructose-Bisphosphate Aldolase (metabolism)
  • Humans
  • Intestinal Mucosa (enzymology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: